exenatide May 19, 2017 exenatide Trade Name Orphan Indication Idiopathic intracranial hypertension USA Market Approval USA USA Designation Date 2017-05-16 00:00:00 Sponsor Alan Boyd Consultants Limited;Electra House, Crewe Business Park;Crewe
